Research and development

Specialist for Immune Sciences

Our research focus

Product pipeline

Phase 1

Phase 2

Phase 3

Approval

Launch

IgG Next Generation (BT595) - Primary Immune Deficiency (PID)
IgG Next Generation (BT595) - Idiopathic Thrombocytopenic Purpura (ITP)
CMV Hyperimmunglobulin (CMVIG) - Prevention of prenatal CMV transmission
Fibrinogen (BT524) - Congenital fibrinogen deficiency
Fibrinogen (BT524) - Acquired fibrinogen deficiency
Trimodulin (BT588) - "Severe" COVID-19
Trimodulin (BT588) - Severe community acquired pneumonia
Haemophilia A Therapeutic (HAT) - Haemophilia A

Pipeline

Pipeline